Identification and characterization of a new splicing variant of vascular endothelial growth factor: VEGF183
- 1 December 1998
- journal article
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression
- Vol. 1443 (3) , 400-406
- https://doi.org/10.1016/s0167-4781(98)00240-1
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Antiangiogenic gene therapyProceedings of the National Academy of Sciences, 1998
- The Biology of Vascular Endothelial Growth FactorEndocrine Reviews, 1997
- Endostatin: An Endogenous Inhibitor of Angiogenesis and Tumor GrowthCell, 1997
- Heterozygous embryonic lethality induced by targeted inactivation of the VEGF geneNature, 1996
- Abnormal blood vessel development and lethality in embryos lacking a single VEGF alleleNature, 1996
- VasculogenesisAnnual Review of Cell and Developmental Biology, 1995
- Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a lewis lung carcinomaCell, 1994
- Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivoNature, 1993
- Regulators of AngiogenesisAnnual Review of Physiology, 1991
- What Is the Evidence That Tumors Are Angiogenesis Dependent?JNCI Journal of the National Cancer Institute, 1990